Mechanism of agonist-induced activation of the human itch receptor MRGPRX1
PLOS Biology · 2023
DOI: 10.1371/journal.pbio.3001975 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Bing Gan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Pruritus, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China project, Chinese University of Hong Kong, Shenzhen Science and Technology Program project.
Abstract (Originalsprache)
Mas-related G-protein-coupled receptors X1-X4 (MRGPRX1-X4) are 4 primate-specific receptors that are recently reported to be responsible for many biological processes, including itch sensation, pain transmission, and inflammatory reactions. MRGPRX1 is the first identified human MRGPR, and its expression is restricted to primary sensory neurons. Due to its dual roles in itch and pain signaling pathways, MRGPRX1 has been regarded as a promising target for itch remission and pain inhibition. Here, we reported a cryo-electron microscopy (cryo-EM) structure of G q -coupled MRGPRX1 in complex with a synthetic agonist compound 16 in an active conformation at an overall resolution of 3.0 Å via a NanoBiT tethering strategy. Compound 16 is a new pain-relieving compound with high potency and selectivity to MRGPRX1 over other MRGPRXs and opioid receptor. MRGPRX1 was revealed to share common structural features of the G q -mediated receptor activation mechanism of MRGPRX family members, but the variable residues in orthosteric pocket of MRGPRX1 exhibit the unique agonist recognition pattern, potentially facilitating to design MRGPRX1-specific modulators. Together with receptor activation and itch behavior evaluation assays, our study provides a structural snapshot to modify therapeutic molecules for itch relieving and analgesia targeting MRGPRX1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai, China.
- The Kobilka Institute of Innovative Drug Discovery, School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, China.
- State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, China.
- Shenzhen Research Institute, Wuhan University, Shenzhen, China.
- Shanghai Qi Zhi Institute, Shanghai, China.
ORCID-Profile: Ruobing Ren
Förderung
- National Natural Science Foundation of China project
- Chinese University of Hong Kong
- Shenzhen Science and Technology Program project
Zitieren
APA
Gan, B., Yu, L., Yang, H., Jiao, H., Pang, B., Chen, Y., Wang, C., Lv, R., Hu, H., Cao, Z., & Ren, R. (2023). Mechanism of agonist-induced activation of the human itch receptor MRGPRX1. PLOS Biology. https://doi.org/10.1371/journal.pbio.3001975
Vancouver
Gan B, Yu L, Yang H, Jiao H, Pang B, Chen Y, et al. Mechanism of agonist-induced activation of the human itch receptor MRGPRX1. PLOS Biology. 2023. doi:10.1371/journal.pbio.3001975
BibTeX
@article{Gan2023,
author = {Gan, Bing and Yu, Leiye and Yang, Haifeng and Jiao, Haizhan and Pang, Bin and Chen, Yian and Wang, Chen and Lv, Rui and Hu, Hongli and Cao, Zhijian and Ren, Ruobing},
title = {Mechanism of agonist-induced activation of the human itch receptor MRGPRX1},
journal = {PLOS Biology},
year = {2023},
doi = {10.1371/journal.pbio.3001975}
}
EUVIMED